Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 16.8
(1.08%)
HKD 16.8
(1.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 41.9 Billion CNY | 2.15% |
| 2022 | 41.02 Billion CNY | 17.93% |
| 2021 | 34.79 Billion CNY | 10.26% |
| 2020 | 31.55 Billion CNY | 2.11% |
| 2019 | 30.9 Billion CNY | 9.05% |
| 2018 | 28.33 Billion CNY | 213.08% |
| 2017 | 9.05 Billion CNY | 9.8% |
| 2016 | 8.24 Billion CNY | 14.7% |
| 2015 | 7.18 Billion CNY | 14.95% |
| 2014 | 6.25 Billion CNY | 19.61% |
| 2013 | 5.22 Billion CNY | 159.91% |
| 2012 | 2.01 Billion CNY | 110.34% |
| 2011 | 956.09 Million CNY | 14.5% |
| 2010 | 835.05 Million CNY | 1.72% |
| 2009 | 820.92 Million CNY | -9.39% |
| 2008 | 905.99 Million CNY | -68.9% |
| 2007 | 2.91 Billion CNY | 18.63% |
| 2006 | 2.45 Billion CNY | 7.16% |
| 2005 | 2.29 Billion CNY | -10.02% |
| 2004 | 2.54 Billion CNY | 20.63% |
| 2003 | 2.11 Billion CNY | 20.6% |
| 2002 | 1.75 Billion CNY | 23.83% |
| 2001 | 1.41 Billion CNY | -9.71% |
| 2000 | 1.56 Billion CNY | 2.8% |
| 1999 | 1.52 Billion CNY | -4.66% |
| 1998 | 1.59 Billion CNY | -6.08% |
| 1997 | 1.7 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 39.85 Billion CNY | -0.34% |
| 2024 Q3 | 41.2 Billion CNY | 3.38% |
| 2024 Q1 | 39.99 Billion CNY | -4.58% |
| 2023 Q4 | 41.9 Billion CNY | 10.35% |
| 2023 Q3 | 37.97 Billion CNY | -0.67% |
| 2023 Q1 | 38.05 Billion CNY | -7.24% |
| 2023 FY | 41.9 Billion CNY | 2.15% |
| 2023 Q2 | 38.23 Billion CNY | 0.46% |
| 2022 Q3 | 35.67 Billion CNY | 5.41% |
| 2022 FY | 41.02 Billion CNY | 17.93% |
| 2022 Q4 | 41.02 Billion CNY | 15.01% |
| 2022 Q2 | 33.84 Billion CNY | 0.04% |
| 2022 Q1 | 33.82 Billion CNY | -2.76% |
| 2021 Q4 | 34.79 Billion CNY | 2.99% |
| 2021 Q2 | 32.64 Billion CNY | -0.9% |
| 2021 FY | 34.79 Billion CNY | 10.26% |
| 2021 Q3 | 33.77 Billion CNY | 3.49% |
| 2021 Q1 | 32.93 Billion CNY | 4.38% |
| 2020 Q1 | 29.35 Billion CNY | -5.01% |
| 2020 Q3 | 30.23 Billion CNY | 7.22% |
| 2020 Q2 | 28.2 Billion CNY | -3.92% |
| 2020 FY | 31.55 Billion CNY | 2.11% |
| 2020 Q4 | 31.55 Billion CNY | 4.35% |
| 2019 Q2 | 28.11 Billion CNY | 3.81% |
| 2019 Q1 | 27.08 Billion CNY | -4.44% |
| 2019 FY | 30.9 Billion CNY | 9.05% |
| 2019 Q3 | 28.39 Billion CNY | 1.02% |
| 2019 Q4 | 30.9 Billion CNY | 8.82% |
| 2018 FY | 28.33 Billion CNY | 213.08% |
| 2018 Q4 | 28.33 Billion CNY | 7.14% |
| 2018 Q3 | 26.44 Billion CNY | 1.37% |
| 2018 Q2 | 26.09 Billion CNY | 201.74% |
| 2018 Q1 | 8.64 Billion CNY | -4.46% |
| 2017 Q3 | 8.28 Billion CNY | -0.06% |
| 2017 Q4 | 9.05 Billion CNY | 9.24% |
| 2017 FY | 9.05 Billion CNY | 9.8% |
| 2017 Q2 | 8.29 Billion CNY | -1.49% |
| 2017 Q1 | 8.41 Billion CNY | 2.1% |
| 2016 Q3 | 7.75 Billion CNY | -5.68% |
| 2016 Q1 | 7.84 Billion CNY | 9.2% |
| 2016 FY | 8.24 Billion CNY | 14.7% |
| 2016 Q4 | 8.24 Billion CNY | 6.33% |
| 2016 Q2 | 8.21 Billion CNY | 4.73% |
| 2015 Q2 | 8.14 Billion CNY | 23.7% |
| 2015 FY | 7.18 Billion CNY | 14.95% |
| 2015 Q4 | 7.18 Billion CNY | -3.85% |
| 2015 Q3 | 7.47 Billion CNY | -8.2% |
| 2015 Q1 | 6.58 Billion CNY | 5.27% |
| 2014 Q1 | 5.65 Billion CNY | 8.13% |
| 2014 Q4 | 6.25 Billion CNY | -5.8% |
| 2014 FY | 6.25 Billion CNY | 19.61% |
| 2014 Q3 | 6.63 Billion CNY | 4.28% |
| 2014 Q2 | 6.36 Billion CNY | 12.6% |
| 2013 Q3 | 5.07 Billion CNY | -3.05% |
| 2013 Q4 | 5.22 Billion CNY | 3.04% |
| 2013 FY | 5.22 Billion CNY | 159.91% |
| 2013 Q1 | 3.15 Billion CNY | 57.05% |
| 2013 Q2 | 5.23 Billion CNY | 65.66% |
| 2012 Q3 | 2.23 Billion CNY | 29.0% |
| 2012 Q4 | 2.01 Billion CNY | -10.18% |
| 2012 Q1 | 1.25 Billion CNY | 31.53% |
| 2012 FY | 2.01 Billion CNY | 110.34% |
| 2012 Q2 | 1.73 Billion CNY | 38.02% |
| 2011 Q3 | 988.77 Million CNY | -9.39% |
| 2011 FY | 956.09 Million CNY | 14.5% |
| 2011 Q4 | 956.09 Million CNY | -3.31% |
| 2011 Q2 | 1.09 Billion CNY | 1.5% |
| 2011 Q1 | 1.07 Billion CNY | 28.74% |
| 2010 Q2 | 990.88 Million CNY | 7.65% |
| 2010 Q3 | 933.82 Million CNY | -5.76% |
| 2010 Q4 | 835.05 Million CNY | -10.58% |
| 2010 Q1 | 920.48 Million CNY | 12.13% |
| 2010 FY | 835.05 Million CNY | 1.72% |
| 2009 FY | 820.92 Million CNY | -9.39% |
| 2009 Q1 | 896.27 Million CNY | -1.07% |
| 2009 Q2 | 890.91 Million CNY | -0.6% |
| 2009 Q3 | 853.78 Million CNY | -4.17% |
| 2009 Q4 | 820.92 Million CNY | -3.85% |
| 2008 Q3 | 954.38 Million CNY | -56.1% |
| 2008 Q2 | 2.17 Billion CNY | 7.21% |
| 2008 Q1 | 2.02 Billion CNY | -30.38% |
| 2008 Q4 | 905.99 Million CNY | -5.07% |
| 2008 FY | 905.99 Million CNY | -68.9% |
| 2007 Q1 | 2.84 Billion CNY | 16.06% |
| 2007 FY | 2.91 Billion CNY | 18.63% |
| 2007 Q4 | 2.91 Billion CNY | -4.36% |
| 2007 Q3 | 3.04 Billion CNY | -1.17% |
| 2007 Q2 | 3.08 Billion CNY | 8.15% |
| 2006 Q3 | 2.75 Billion CNY | 6.13% |
| 2006 Q2 | 2.59 Billion CNY | 0.86% |
| 2006 FY | 2.45 Billion CNY | 7.16% |
| 2006 Q1 | 2.57 Billion CNY | 12.49% |
| 2006 Q4 | 2.45 Billion CNY | -11.0% |
| 2005 Q4 | 2.29 Billion CNY | -11.98% |
| 2005 Q3 | 2.6 Billion CNY | -0.84% |
| 2005 Q2 | 2.62 Billion CNY | -6.75% |
| 2005 Q1 | 2.81 Billion CNY | 10.55% |
| 2005 FY | 2.29 Billion CNY | -10.02% |
| 2004 Q3 | 2.36 Billion CNY | 3.86% |
| 2004 Q4 | 2.54 Billion CNY | 7.45% |
| 2004 Q2 | 2.28 Billion CNY | 3.25% |
| 2004 FY | 2.54 Billion CNY | 20.63% |
| 2004 Q1 | 2.2 Billion CNY | 4.7% |
| 2003 Q2 | 1.9 Billion CNY | -5.02% |
| 2003 Q3 | 2.04 Billion CNY | 7.28% |
| 2003 Q4 | 2.11 Billion CNY | 3.14% |
| 2003 FY | 2.11 Billion CNY | 20.6% |
| 2003 Q1 | 2 Billion CNY | 14.75% |
| 2002 Q4 | 1.75 Billion CNY | 14.04% |
| 2002 Q1 | 1.45 Billion CNY | 3.09% |
| 2002 Q2 | 1.49 Billion CNY | 2.87% |
| 2002 Q3 | 1.53 Billion CNY | 2.39% |
| 2002 FY | 1.75 Billion CNY | 23.83% |
| 2001 Q2 | 1.54 Billion CNY | 0.0% |
| 2001 FY | 1.41 Billion CNY | -9.71% |
| 2001 Q4 | 1.41 Billion CNY | 0.0% |
| 2000 FY | 1.56 Billion CNY | 2.8% |
| 2000 Q4 | 1.56 Billion CNY | 0.0% |
| 1999 FY | 1.52 Billion CNY | -4.66% |
| 1998 FY | 1.59 Billion CNY | -6.08% |
| 1997 FY | 1.7 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -29354.923% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | -478.47% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -24493.505% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -5805.562% |
| Qianhai Health Holdings Limited | 94 Million HKD | -44482.677% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | -4406.016% |
| Essex Bio-Technology Limited | 903.78 Million HKD | -4537.079% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -6198.429% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -5976.85% |
| SSY Group Limited | 4.49 Billion HKD | -832.57% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -11327.051% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | -3743.126% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 75.122% |